NEWS

Contributions from GlaxoSmithKline to Calif. Legislators

Jeffrey ErnstFriedman | July 14, 2010

On Tuesday the U.S. Senate Finance Committee released a report on an investigation into safety issues surrounding Avandia, a diabetes drug developed by GlaxoSmithKline. MAPLight.org reported that the drug manufacturer has given $3,388,975  to lawmakers at the federal level since 2002. In separate contributions, GlaxoSmithKline has contributed $345,959 to California state lawmakers in the same timespan. Click here to find out how much your representative has received using MAPLight.org's contribution search form.

Media Contact:
press@maplight.org
510-868-0894